Literature DB >> 3013317

In vitro formation of bile acids from di- and trihydroxy-5 beta-cholestanoic acid in human liver peroxisomes.

B F Kase, K Prydz, I Björkhem, J I Pedersen.   

Abstract

The conversion of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-[3H]cholestanoic acid into cholic acid and 3 alpha,7 alpha-dihydroxy-5 beta-[3H]cholestanoic acid into chenodeoxycholic acid has been studied in subcellular fractions of human liver. The products were separated from the substrates by high-pressure liquid chromatography and identified by combined gas chromatography-mass spectrometry. The highest rates of conversion were found in the light mitochondrial fraction. This fraction also contained the highest amount of the marker enzymes for peroxisomes. The maximal rates of cholic acid and chenodeoxycholic acid formation were 1.3 and 1.8 nmol/mg protein per h, respectively. The presence of KCN in the incubation medium stimulated the formation of bile acids. Peroxisomes were prepared from the light mitochondrial fraction by sucrose-gradient centrifugation. By use of different marker enzymes, it was confirmed that the major part of the activity for cholic acid formation in the light mitochondrial fraction was located in the peroxisomes. It is concluded that liver peroxisomes are important for the oxidative cleavage of the C27 steroid side chain in bile acid formation in man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013317     DOI: 10.1016/0005-2760(86)90115-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  The inborn errors of peroxisomal beta-oxidation: a review.

Authors:  R J Wanders; C W van Roermund; R B Schutgens; P G Barth; H S Heymans; H van den Bosch; J M Tager
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Deficient oxidation of trihydroxycoprostanic acid in liver homogenates from patients with peroxisomal diseases.

Authors:  M Casteels; C W Van Roermund; L Schepers; L Govaert; H J Eyssen; G P Mannaerts; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 3.  Zellweger syndrome: biochemical procedures in diagnosis, prevention and treatment.

Authors:  R B Schutgens; R J Wanders; H S Heymans; A W Schram; J M Tager; G Schrakamp; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 4.  Biochemistry of peroxisomes in health and disease.

Authors:  I Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

5.  Fatty acid synthesis from [2-14C]acetate in normal and peroxisome-deficient (Zellweger) fibroblasts.

Authors:  A Poulos; S Usher; B C Paton
Journal:  Lipids       Date:  1993-02       Impact factor: 1.880

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.